By contrast, Galectin-1 underexpression inhibits the expression of the sorafenib-mediated ferroptosis markers GPX4 and FTH1 and increases lipid peroxidation, restoring the sensitivity to sorafenib of sorafenib-resistant HCC cells. The gene discussed is GPX4; the disease is hepatocellular carcinoma.